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INTRODUCTION 
Breast lumps are one of the common problems encountered in 
women. These lumps are frequently seen in younger to middle aged women 
and often they go undetected for various reasons. These lumps have different 
etiologic causes and can be either benign of malignant. In India breasts are 
considered as symbol of womanhood and fertility and there is a taboo 
surrounding discussion about breast lumps and hence the women come to 
the hospitals for examination only later in the course of the disease.    
Mostly these lumps are benign, but breast malignancy is the most 
common form of cancer and is the second leading cause of malignancy 
deaths in women, next only to lung cancer in Asian and black women but is 
the leading cause of death in Hispanic women. Hence early recognition of 
malignancy plays a vital role for improving survival. Fibro adenoma is the 
most common benign breast mass and invasive ductal carcinoma is the most 
common malignancy. In recent studies it has been shown that there is a 
significant rise in incidence of breast masses in women younger than the age 
of forty. Only less than half of the women with breast cancer are alive and 
disease free after ten years of diagnosis.  
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So the need of the hour is a system to detect malignancy earlier and 
minimize the time needed for the detection of malignant lumps. The 
approach to diagnosis is multi pronged and should include clinical 
examination, imaging, cytological tests and histopathological examination. 
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AIM AND OBJECTIVES 
 
This study is done to determine the clinical characteristics of palpable 
breast lumps and with the objective of detecting malignancy earlier in 
patients presenting with palpable breast lumps using a modified triple test 
which includes a complete clinical examination of the Breast lump, 
Ultrasonography of the Breast, and Fine Needle Aspiration Cytology of the 
Breast lump. 
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REVIEW OF LITERATURE 
 
ANATOMY 1, 2 
The mammary gland or breast is a modified sweat gland and is one of 
the accessory reproductive female organs. 
It is situated in the chest wall in the superficial fascial layer of the 
pectoral region a part of the breast enters the axillary region by piercing the 
deep fascia and it is called as the Axillary tail of Spence.  
The extent of the breast varies from person to person and it usually 
extends vertically from the second rib to the sixth rib and horizontally from 
the sternum to the mid axillary line.  
Deeper to the breast are the deep fascia of pectoralis major and beyond 
this are the muscles, the Pectoral muscles, the Serratus Anterior and the 
External oblique muscle.  
The main breast tissue is separated from the deeper structures by loose 
areolar tissue. 
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1. SKIN 
It envelops the mammary gland. A cone shaped projection called 
nipple is present at the centre of the gland at the level of fourth intercostal 
space. Fifteen to twenty lactiferous ducts pierce the nipple and communicate 
with exterior. The nipple can be made flat or stiff using circular and 
longitudinal muscle fibers; the skin around the nipple is pigmented for a 
short distance from the center which is called as the areola. 
 
 
 
 
 
 
 
 
FIGURE 1- ANATOMY OF THE BREAST 
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2. THE PARENCHYMA 
The parenchyma of the breast is composed of fifteen to twenty lobes; 
each lobe is composed of several lobules. A bunch of alveoli form a lobe and 
each lobe is drained by a lactiferous duct. The lactiferous ducts reach the tip 
of the nipple and open through it, the lactiferous sinus is a dilatation in the 
lactiferous duct near its termination.   
3. STROMA 
The main bulk of the gland is formed by the fatty stroma, the fibrous 
bands traverse through the fatty stroma and is called as the suspensory 
ligament of Cooper, these structures insert into the dermis perpendicularly 
which gives structural support to the breast.   
BLOOD SUPPLY OF BREAST1 
The breast is a highly vascular organ and the principal arteries 
supplying the breast are 
1. Internal mammary artery, a branch of the subclavian artery 
through its perforators. 
2. The lateral thoracic, superior thoracic and pectoral branches of 
acromiothoracic artery which are branches of the axillary 
artery. 
3. Posterior intercostal arteries through its lateral branches. 
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VEINS OF THE BREAST1 
The breast veins follow the arterial course and drain into the axillary 
region. The three groups of veins are 1. perforating branches of internal 
thoracic vein 2. Perforating branches of posterior intercostal veins and               
3. The tributaries of the axillary veins, these veins communicate with a 
plexus of veins which extends from the skull base to the sacrum, known as 
the Batson’s venous plexus which might serve as a route through which 
carcinoma of the breast tissue might metastasize to the vertebral bones, 
skull, pelvic bones and the CNS. 
NERVE SUPPLY OF THE BREAST1 
Sensory innervation of the breast and the anterolateral chest wall is 
through the lateral cutaneous branches of the third to sixth intercostal nerves 
and anterior branches of the supraclavicular nerve supply the upper portion 
of the breast. The intercosto brachial nerve which is a branch of second 
intercostal nerve may be encountered during axillary dissection and injury 
causes loss of sensation over the medial portion of the upper arm. 
LYMPHATIC DRAINAGE OF THE BREAST1 
Lymphatic drainage of the mammary gland is of great importance to 
the surgeon, since breast malignancy spreads usually along lymphatics to the 
regional lymph nodes. 
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FIGURE 2 - REPRESENTING LYMPHATIC DRAINAGE OF THE BREAST 
 
LYMPH NODES 
The lymphatic drainage of the breast is through the following group of 
nodes, 
1. The axillary node groups, mainly the anterior (or pectoral) 
group. The posterior (or subscapular),axillary vein (or lateral), 
central and apical(or subclavicular ) groups of nodes also 
receive lymphatic drainage from the breast tissue  either 
indirectly or directly. 
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2. The internal mammary nodes also called as the parasternal 
nodes lie besides the internal thoracic vessels. 
3. Few  lymphatics from the breast also communicate with the 
supraclavicular , the deltopectoral node, the posterior intercostal  
groups and  the infradiaphragmatic and subperitoneal lymphatic 
plexuses. 
The skin of the breast with the exception of nipple and areola is 
drained by the superficial lymphatics , these lymphatics travel in a radial 
fashion from the centre and ultimately drain into the axillary, internal 
thoracic, supraclavicular and the cephalic lymph node groups.  
The parenchyma of the breast, the nipple and areola are drained by the deep 
lymphatics. 
Some interesting points about the lymphatics of the breast are as follows, 
1. Axillary group of lymph nodes receives more than 75% of the 
lymphatics from the breast tissue and about 20% drain into the 
internal mammary node groups; and remaining 5% drain into 
the posterior intercostal lymph nodes. The anterior axillary 
group of lymph node receives most of the lymphatics from the 
breast and apical and posterior group receive only a small part. 
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2. The parasternal nodes receive the lymphatics not only from the 
medial region of the breast, but also from the lateral region of 
the breast. 
3. A lymphatic plexus called the subareolar plexus of Sappy is 
present beneath the areola and this plexus drains into the 
anterior or pectoral group of lymph nodes. 
4. The deep lymphatics of the breast finally reach the apical and 
internal mammary group of lymph nodes after traversing 
through the pectoral muscle and its fascia. 
5. The infradiaphragmatic and subperitoneal plexuses receive 
some lymphatics from the lower and medial quadrants of the 
breast. 
LEVELS OF LYMPH NODES1, 2 
The lymphatic groups are allotted levels according to their 
relationship to pectoralis minor muscle as follows, 
Level 1 nodes: situated lateral to the inferior border of the muscle, which 
include anterior, posterior and lateral groups. 
Level 2 nodes: located deep to the muscle which consists of central nodes 
and Rotter’s (or interpectoral nodes) nodes. 
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Level 3 nodes: located medial to the superior border of the muscle which 
include subclavicular nodes. 
 
PHYSIOLOGY AND DEVELOPMENT OF THE BREAST3, 4, 5 
The development of breast starts in the fifth week of intrauterine life 
but is completed fully only after the first full term pregnancy. The milk line 
which is an ectodermal thickening extending from the axilla to groin is 
formed during the 5th week of intrauterine life, in the subsequent weeks the 
portion of the milk line in the mammary region forms the mammary crest 
and the remainder of the milk line involutes. The primary nipple bud formed 
from the ectoderm grows into the mesenchyme and forms about 20 
secondary buds, these later on form the lactiferous ducts and their 
ramifications. 
The breast remains dormant until puberty in the female, at puberty the 
hormonal changes lead to its development and fat deposition, but the 
development is complete only during pregnancy, when terminal ductal 
differentiation occurs and gets ready for milk secretion. Later involution of 
the breast occurs, which is pronounced during menopause when the acini 
decrease in number and size, the connective tissue replaces the stroma and 
finally fat deposition increases and epithelial elements decreases. 
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TUMOURS OF THE BREAST1, 2 
Most of the breast problems are benign conditions and about 30 % of 
women will seek treatment for a benign breast condition in their lifetime, 
pain and lump in the breast are the most common clinical features, so it 
becomes the need of the hour to exclude malignancy. 
BENIGN BREAST CONDITIONS  
Aberrations of Normal Development and Involution (ANDI) is a 
terminology used to describe the disturbance in physiology and cytology of 
the breast and ranges from  normal to disorder to disease.  
It consists of essentially 4 features  
Formation of Cyst – variable in size and found universally  
Fibrosis – elastic and fat tissues are replaced by fibrous tissue with 
interspersed chronic inflammatory cells.  
Hyperplasia – proliferation of acinar and ductal epithelia with or without 
cellular atypical changes. 
Papillomatosis – extensive epithelial hyperplasia resulting in papillomatous 
changes.  
Clinical features  
Include lump with or without pain. 
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Fibroadenoma  
Fibrodenoma is the commonest cause of benign breast lump; it is a 
non proliferative disorder of breast occurs in the age group of 15 to 25 years 
but occasionally seen in much elder women. They have plenty of stroma 
where cellular elements are histologically normal, similar to normal lobules 
of breast. They are hormonal dependent, fibroadenomas lactate during 
pregnancy and involute after menopause, so it is a self limiting condition. 
Ultrasonogram of breast will reveal pathognomonic features of 
fibroadenaoma. In fibroadenomas of size less than 3 cm excision may be 
avoided, Fibrodenomas of size more than 3 cm are best managed by surgical 
excision.  
Periductal mastitis, duct ectasia and breast cysts are other important 
non proliferative disorders. 
Fibrocystic disease   
Fibrocystic disease can present with lump and or pain it may be 
confused with carcinoma breast at times and usually resolves after 
menopause. 
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Breast Macrocysts  
These are involution disorders that usually occur in the later stages of 
reproductive life. Breast cysts of often multiple, bilateral and can mimic 
carcinoma; diagnosis is usually confirmed by ultra sonogram and aspiration. 
If the cyst is a complex one or the aspirated fluid is blood stained or residual 
mass is present after aspiration we have to suspect malignancy, which is 
confirmed by cytology or tissue biopsy. 
Intraductal papilloma  
It is a proliferative breast disorder arising from major ducts it usually 
occurs in premenopausal women usually presents with nipple discharge, 
malignant transformation is rare unless there is atypia. 
Multiple intraducatal papilloma usually occurs in younger age group 
and may undergo malignant transformation. 
Phyllodes tumour  
It usually occurs in fourth decade of life, cystosarcoma phyllodes tumors 
are classified as  
1. Benign phyllodes tumours. 
2. Borderline phyllodes tumours. 
3. Malignant phyllodes tumors  
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  These tumors are large and massive at times and the surface of the 
tumors are unevenly bosselated, main bulk of the phyllodes tumor are 
composed of connective tissues mixture of cystic, solid and gelatinous areas.  
Infarction and necrosis at certain sites forms cystic areas.   
 Leaflike appearance (phyllodes means leaf like ) which is a classical 
feature of phyllodes tumour is due to this gross morphological alteration , 
small tumours are treated by wide local excision and large tumours may 
need mastectomy , borderline and malignant phyllodes tumours are highly 
recurrent.  
Breast abscess 
The most common organism causing lactational infection is Staph 
aureus. Duct ectasia and periductal mastitis are polymicrobial , here a series 
of infections results in scarring which may lead to inversion and retraction of 
the nipple and palpable mass in the subareolar region , so it is challenging to 
exclude malignancy here. 
Sclerosing adenosis 
Increase in number of small distal ductules with stromal tissue 
proliferation produces sclerosing adenosis it is difficult to differentiate from 
carcinoma both grossly and histologically. 
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Fat necrosis 
Fat necrosis may occur following any trauma or previous surgical 
procedure or exposure to radiation, characteristic feature is calcifications 
which can be visualized by ultra sonogram. 
 
BREAST CANCER  
Breast carcinoma is the commonest site specific carcinoma in women; 
it is a leading cause of mortality from malignancy for females in the age 
group of 20 to 60 years. 29 % of all newly detected malignancy in female 
population are breast cancers, it accounts for 14% of the malignancy related 
mortality in females. There is gross variation in the incidence of carcinoma 
breast among various countries.  
Worldwide, Cyprus and Malta account for the highest age adjusted 
mortality for carcinoma breast and Haiti accounts for the lowest age adjusted 
mortality. There is increase in incidence in China and East Asia up to 3 to 
4% annually.  Breast carcinoma burden has well defined differences by 
regional lifestyle, geography and ethnic background.  Asian and African 
women have a lower incidence of breast cancer occurrence and mortality. 
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The highest burden of disease is seen in European and North 
American women. Due to absence of effective screening programmes for 
earlier detection of malignancy and lack of accessibility to multidisciplinary 
treatment programmes underdeveloped countries have disproportionate 
mortality risk.  
DIAGNOSIS OF A BREAST LUMP 
Early detection of breast pathology forms is very important and in this 
regard self examination of breast plays a great role. The 2013 NCCN 
guidelines states that in addition to frequent breast self examination a 
clinical examination of breast by medical personnel is recommended once in 
a year.  
Usually breast disease presents as a painless lump in the mammary 
gland, discharge or erosion of the nipple, puckering or retraction of the skin 
over the breast or swelling in the axillary region. 
In order to arrive at a clinical diagnosis of breast lump and to detect 
whether it is a benign or malignant lesion several modalities are used they 
include detailed clinical examination of the breast , imaging tests like 
mammography or ultra sonogram and thermography or tissue or cytology 
based tests like excision biopsy , core needle biopsy or fine needle aspiration 
cytology. 
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 If these tests if used alone the diagnostic yield is not much , hence 
nowadays a combination of several tests are used for screening the patients 
who have a breast lump for the earlier detection of a malignant condition, 
this combination improves the sensitivity and specificity thereby cutting 
down time and cost in diagnosis. 
In India carcinoma Breast is the most common malignancy in females 
and worldwide it is the foremost cause of malignancy related death among 
women. Hence the diagnosis of a breast lump assumes utmost importance 
both for the clinician and the patient, a dominant breast mass by definition is 
a cystic or solid mass that is present in the substance of the breast throughout 
the menstrual cycle. 
Clinical assessment of breast masses  
The Clinician is the person responsible for the diagnosis of a breast 
mass, most of the breast lumps are benign, but diagnosis of malignancy 
poses a great challenge and in most of the cases a history and clinical 
examination however meticulously performed, will be inadequate to arrive 
at definite diagnosis.  
The breast has a lobular architecture and the identification of smaller 
lumps amongst this lobularity is a great challenge and hence adjunctive 
imaging modalities form an integral part of the examination of breast.  
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The imaging studies of breast dates back to as early as 1913 when a 
German pathologist Salomon used X-rays to examine the amputated 
specimens of the female breast , the demonstration of micro-calcification 
and heterogeneity in X-ray  in cases of malignancy still holds good6 . This 
investigation has stood the test of time and evolved as mammography which 
is still being used as a screening test for breast malignancy. 
Since mammography involves radiation and studies have proven that 
patients subjected to mammography are at a slightly increased risk of 
development of malignancy in situ, the use of other economically viable and 
safe imaging modalities was considered. 
 
ULTRASONOGRAPHY OF BREAST  
The examination of breast tissue by ultrasound was proposed as early 
as 1950 but could be put into clinical practice only after the development of 
grayscale examination by Swedish scientists and then tissues could be 
clearly examined. In recent era the advances in ultrasound technology has 
made it into a safe economical and reliable method for the examination of 
superficial and moderately deeply situated soft tissue lesions, and the 
examination can give more information than differentiating cysts from solid 
tumours and can also guide in planning FNAC or core biopsy. 
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TISSUE DIAGNOSIS  
The gold standard for the detection of malignancy remains the 
demonstration of malignant cells in the tissue specimen and FNAC and 
excision biopsy are used for this.  
In 1912 FNAC was used for the examination of cause of lymph node 
enlargement and gradually it percolated to other fields for neoplasia 
evaluation and in 1962 Ellis and Martin used FNAC for the evaluation of 
breast masses7, FNAC interpretation is operator dependent and it requires 
years of experience to master this technique and experienced operators can 
distinguish benign and malignant lesions with good accuracy. 
    
CLINICAL EXAMINATION 
Inspection and palpation of breast masses are important and in order 
to become palpable the mass should be large enough to be distinct from the 
tissues surrounding it. But it might be detected earlier on imaging  
modalities, Since the breast mass is lobular with varying contents of 
glandular tissue, adipose tissue and fibrous tissue, the exact identification of 
breast masses might pose a difficulty to the examiner.  
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But true breast masses stand out from the surrounding tissues with a 
different consistency and are asymmetric when both breasts are compared 
and have a three dimensional demarcation from surrounding tissues.  
Of the breast diseases, benign breast diseases predominate but the fear 
that a breast disease creates is enormous and a plan should be devised for the 
rapid detection and treatment of malignancy, of this first are history and 
physical examination.  
A detailed history includes the following points:  
 Age at presentation   
 Menstrual history 
 Family history and reproductive history 
 History of pregnancy and lactation  
 Exposure to radiation especially the upper body 
 H/o benign breast disease  
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PHYSICAL EXAMINATION OF BREAST  
A private examination cubicle with proper lighting with adequate 
warmth and comfort are essential for breast examination, the room should be 
properly illuminated and the patient is stripped up to the waist to enable a 
complete examination. 
General examination  
 Built and Nourishment  
 Colour of skin  
 Mucous membranes  
 Palms and soles  
Inspection of breast  
First examine the patient from bed end with arms by side and then 
with arms elevated.  
The symmetry of breasts and nipples are first assessed  
The next points for inspection are  
a. Abnormalities of the nipple and areola  
b. Prominent vessels and scars  
c. Prominence or dimpling of the skin  
d. Skin Tethering 
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e. Peau d’ orange appearance  
f. Nodules over the surface  
g. Skin or Nipple Ulceration 
 
 Palpation of breast is done in an orderly fashion, the following is the 
schema  
1. Palpation of both Supraclavicular fossa 
2. Breasts: 
a. Initially light palpation is done, followed by 
b. Deep palpation extending systematically from the areola 
and moving concentrically outwards to the axilla 
including the axillary tail. 
3. Examination of Axilla: 
a. Examine the axilla from front and behind 
b. The forearm of the patient is supported by the examiner 
4. Abdomen is examined for ascites, organomegaly or abnormal 
masses. 
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 Particularly valuable in practice are 
 Inspection with arms firstly kept by the side, then arms raised.  
 First light palpation over the breasts followed by deep palpation 
in concentric rings, travelling outwards. 
 Examination of the both axillae performed from front and back 
of the patient. 
Malignant tumours are usually firm or hard and tend to have ill-
defined margins and attachments to the overlying skin or fascia with 
puckering or retraction of the nipple and areola. Benign lesions are well 
defined and have clear borders and are mobile without definite attachments 
to superficial or deeper tissues. 
Solid lesions and cystic lesions can be differentiated by palpation to a 
certain extent but the sensitivity of palpation is only around 58 to 66% as 
reported by Rosner et al, so significant difference in diagnosis can be present 
even among seasoned examiners8 , In a study done by Boyd et al  involving 
patients with breast masses which had experienced surgeons doing physical 
examination the need for biopsy was agreed upon only in 73% of patients 
with malignancy.                    
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In another study, Somers et al studied certain palpable abnormalities 
which were defined as areas of thickening, tenderness without an associated 
dominant mass on clinical examination, no suspicious mammography 
findings and firm, rubbery, cystic soft mass, needle sensation by FNA. The 
malignancy incidence in this group was less than 1%, so it was concluded 
that these palpable lesions did not require open biopsy. 
Sometimes in the earlier stages of malignancy benign features and 
malignant features may overlap and without the use of FNAC or imaging 
modality certain malignant lesions may be classified as benign by physical 
examination causing a delay in treatment, So in order to arrive at an early 
definitive diagnosis an imaging modality is required to complement the 
findings of physical examination and for the examination of the opposite 
breast and look for multi-centricity.  In the contrary a negative imaging 
finding in a highly suspicious looking lesion also should be interpreted with 
caution.   
ULTRASONOGRAPHY OF BREAST 
Ultrasound Examination of breast has been in vogue since 1950s but 
the resolution and technology was inadequate for a comprehensive 
examination in the earlier phases, hence physicians were not able to utilize 
the investigative potential, later the development of grayscale ultrasound 
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technique by Korasakoff obviated this difficulty and ultrasound began to be 
used in a widespread fashion. 
 The ultrasound transducers were initially quite crude devices that 
operated with low frequencies.30  
Low frequency waves have good penetration but the image resolution 
is not adequate hence initial ultrasonography had a low sensitivity to 
differentiate between tissue types.  
Later generation transducers were improved with design changes that 
allowed use of a range of frequencies and higher frequency transducers were 
used for examination of breast, thyroid and testis. 
Even with modern ultrasound technology, ultrasound examination is 
operator dependent and adequate training is essential for the correct 
interpretation of findings.  
Skilled Sonography interpreters follow three golden rules, they are 
1. A single image is never used for making an interpretation but a 
mental 3 dimensional image is imagined with the acquired 
images; superimpose the ultrasonic images mentally to 
formulate a 3 dimensional image of the scanned tissues and to 
ensure that the displayed feature is concordant with the mental 
image. 
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2. Rule out artifacts; don’t always think that all which is displayed 
in the image is real. 
3. Look for the invisible things, things which are not seen in a 
field of imaging can be seen in other planes.  
 
Initially ultrasound could differentiate only between solid and cystic 
masses but later generations of Ultrasound devises are capable of 
characterizing the density of tissues and can be used to differentiate between 
benign, malignant and equivocal masses.70 
 
ULTRASONOGRAPHY OF THE BREAST  
First task is to confirm the side of breast, site and position of the 
lesion which is to be evaluated; this can be done by referring the clinician’s 
notes and the diagrams provided by the examining physician  
For Breast USG, a 7.5 to 10 Mhz linear- small parts high definition 
transducer is used. 
The Region of interest (ROI) is first evaluated and the side and Site 
are confirmed to be in concurrence with request given and USG findings are 
correlated with clinical findings.  
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Position of the patient  
A pillow is placed under the shoulder of the side to be examined, the 
patient is made to lie in an oblique position with the degree of obliquity 
depending on the position of the breast, this aims to bring the corresponding 
breast to the centre of the examination field, the arm is raised above the 
patients head for even distribution of the breast tissue, but not very much as 
to cause breast retraction. Better positioning eases examination and provides 
clear images.  
a. Lesions that are felt better in the upright position may be 
scanned in the same position.  
b. Confirmation of fluid in cysts can be done by changing from 
upright to decubitus position. 
The Ultrasound transducer is placed directly over the lesion after 
trapping the region of interest with the examiners fingers. 
Examination should be done in radial/antiradial planes to avoid 
mistaking fat islands as solid masses and determine the relation of the lump 
to the ducts.  
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Shape, nature of margins and surrounding tissue can be determined by 
evaluating the lesion in entirety including the periphery, in multiple planes. 
Artifacts can be eliminated by slightly compressing the breast tissue 
with transducer which will make the breast tissue to spread evenly over the 
chest wall. 
The breast is examined from the periphery to centre and finally the 
areola and nipple are imaged and the retroareolar tissue is also imaged in 
multiple planes by angling the transducer.30 
 LESION LABELING 
 The position lesion is labeled on a clock face.  
 The distance of the lesion from nipple is given in centimeters. 
 The longest diameter is measured. 
 Height width ratio of the lesion is obtained.  
NORMAL APPEARANCE OF THE BREAST 
  Knowledge about breast architecture and its normal variations are 
important for the accurate detection of the abnormalities of breast.30  
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SKIN  
The skin appears as an echogenic layer with a thickness of 3mm or 
less by ultrasound and most of the times a hypo echoic central line is seen, if 
the skin is diffusely thickened it is difficult to recognize it without 
comparing the Region of Interest to the opposite breast or to a normal area 
within the same breast. To detect subtle abnormalities a standoff pad may be 
used.     
 
SUBCUTANEOUS TISSUE 
 The subcutaneous fat layer is present beneath the skin as a hypo 
echoic layer sandwiched between the skin line and the parenchyma of the 
breast. The ligaments of Cooper are seen as curvilinear lines extending from 
the breast parenchyma to the superficial fascial layer thereby producing a 
scalloped appearance. Cancer breast does not arise in the subcutaneous plane 
but it might involve it by direct extension. 
  Focal increase in echo texture is seen in Malignancy, 
inflammatory lesions, fat necrosis, edema, or biopsy scar. 
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  Diffuse increased reflectivity of breast tissue is seen in edema of any 
cause (e.g., Congestive Cardiac failure), diffuse form of Carcinoma breast, 
inflammatory breast cancer, inflammatory mastitis, or radiotherapy to breast. 
Sebaceous cysts, epidermoid cysts, hemangiomas, and rarely smooth 
muscle and fibrous tissue tumors are the indigenious to this plane. 
NIPPLE AND AREOLA  
The Nipple and areola are imaged after compressing the area slightly 
with the transducer and imaging is done in multiple planes angled towards 
the subareolar region, application of light pressure with the transducer 
prevents air trapping between the skin and the transducer thereby 
eliminating artefacts , The lactiferous ducts are visualized in this area and 
they are traced into the breast tissue , usually echogenic masses represent 
debris collected within, but the presence of a dilated duct along with a mass 
lesion may indicate carcinoma , papilloma or other solid lesions.   
BREAST PARENCHYMAL LAYER 
 The breast parenchymal tissue has varying proportions of ductal, 
lobular and fibrous tissue. In younger age the breast tissue is dense and 
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uniform, as age advances the breast become more lobular, but age and parity 
do not exactly correlate with the ultrasound appearance of breast. 
The normal breast can range from almost completely fatty with only a 
few ehogenic fibroglandular tissue in one spectrum to presence of more 
amount of fibroglandular tissue with little or no fat on the other. 
The normal fibroglandular tissue appears to be arranged in multiple 
layers parallel to the chest wall without distortion and should not have a 
pulled or swirled appearance. 
Most benign and malignant lesions are imaged as  hypoechoic nodules 
in comparison with the paraenchyma and are  easily visualized the  in 
homogenously echogenic breast tissue, which does not deform with 
compression. Moreover, the most useful maneuver in imaging of the breast 
is to image in multiple planes, which helps to demonstrate the fat island 
continuity with other areas of fat.  
RETROMAMMARY AREA  
It is present deeper to the echogenic plane of glandular tissue, and 
visualization by ultrasound is difficult, it is a hypoechoic plane containing 
fat. 
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LYMPHNODES, ARTERIES, AND VEINS 
 Lymphnodes are seen within the axillary region as round to oval 
nodules with an hilum which is more echogenic and a peripheral rim of less 
echogenic tissue. 
Benign nodes are large in size but morphology is preserved but 
malignant nodes appear as hypoechoiec lobulated nodules. Ultrasound can 
only detect gross abnormalities and not minor variations in lymph nodes. 
 Arteries and veins appear as tubular anechoic structures within the 
breast tissue. Arteries have a pulsatile appearance on the examination of the 
breast; Colour Doppler ultrasound can clearly demonstrate the vascular 
structures.  
BREAST MASS CHARACTERIZATION 31 
CYSTS  
The characterization of breast mass starts with solid and cyst 
differentiation, the accuracy of USG approaches 100% for the diagnosis of 
cystic breast masses when all the diagnostic criteria for cysts are met.   
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These are the criteria  
a. Oval, lobulated or round shape  
b. Anechoic  
c. Clearly defined posterior border  
d. Increased through and through transmission  
e. Surrounding parenchyma shows no alteration.  
 
But in real life situations all cysts do not display these criteria. Cysts 
of size up to 5mm can be diagnosed with USG with an accuracy approaching 
100%. The common difficulty in the differentiation of cysts from solids is 
when internal echoes are present. Internal echoes may be seen in cysts due to 
presence of calcium or cholesterol, hemorrhage within the cyst or infection.  
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FOLLOW UP OF CYSTS 32 
 
SIMPLE CYSTS  
 
 
 
 
 
 
  
COMPLEX CYSTS  
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SOLID MASSES 
Solid masses have the following signs by USG 
Primary signs – changes produced by the mass per se.  
Secondary signs – changes in the surrounding tissues due to the mass.  
 
BENIGN FEATURES OF SOLID MASSES  
USG has less specificity in differentiating benign masses from each 
other.  
There is overlap of findings between fibroadenomas, tubular 
adenoma, focal fibrocystic changes and other solid benign nodules. 
Features of solid benign lesions are 
1. Shape is round or oval with few lobulations. 
2. Presence of a thin echogenic pseudocapsule with sharply 
defined margins. 
3. A depth/width ratio of less than 1.  
4. Surrounding tissues clear of disease.  
5. Absence of malignant characteristics, by Ultrasound guided 
aspiration or biopsy. 
6. Presence of homogenous low level internal echoes.  
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FIBROADENOMAS  
Fibroadenomas are the most common benign solid nodules. 
Fibroadenomas are seen in young females and their ultrasound features are 
determined by the varying amounts of epithelial and fibrous components.    
 The features of Fibroadenomas are  
 
a. Enhanced through and through transmission.  
b. Posterior attenuation in relation to the fibrous component. 
c. Degenerating fibroadenomas have shadowing in USG due to 
coarse calcifications.  
d. Lactating and juvenile types of fibroadenomas exhibit tubular 
structures.  
e. Differentiated from fat lobules by their non compressible 
nature.  
LIPOMAS AND FIBROADENOMYOLIPOMA  
1. Lobulated masses with no distortion of surrounding tissues.  
2. Presence of internal echoes due to fat content. 
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FAT NECROSIS  
 Fat necrosis is seen as a hyperechoic nodule with a central lucency.  
 
ULTRASOUND IMAGES 
 
 
 
 
 
 
 
                      NORMAL BREAST                            BREAST CYST 
 
 
 
 
 
 
 
                       BENIGN LESION                                      MALIGNANCY 
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MALIGNANT FEATURES OF BREAST LESIONS  
1. Stellate lesions  
2. Circumscribed lesions   
3. Presence of diffuse edema  
4. Presence of calcifications  
 
STELLATE MASSES  
The normal parallel arrangement of soft tissue planes in malignant 
tumours is lost and the desmoplastic reaction in and around the lesion pulls 
the breast tissues towards the mass resulting in a stellate appearance.  
The centre of the lesion is irregular and hypoechoic and there is 
peripheral distortion producing a star like appearance and the features are  
 Normal trabecular architecture is disrupted.  
 Extension of disease along the plane of the ducts.  
 Posterior acoustic shadowing is seen.  
  Subcutaneous tissue has increased reflectivity.  
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Differential diagnosis of stellate lesions  
 Carcinoma (commonest)  
 Radial scar  
 Sclerosing adenosis  
 Post operative scarring  
INDICATIONS FOR BREAST ULTRASOUND  
1. To evaluate a breast lump that is detected by mammography. 
2.  To confirm the nature and the presence of a lesion.  
3. Used as a single imaging method in pregnant or lactating 
women who present   with breast symptoms and in outpatient 
setups.  
4. To delineate solid from cystic lesions.  
5. Used to guide biopsy /aspiration for pathological diagnosis.  
6. Used for localization of lesions in preoperative stages and to aid 
surgical excision. 
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7. Follow up of post surgical breast tissue.  
8. Post breast augmentation surgery follow up to investigate the 
contour of prosthesis or to find out extra capsular rupture. 
9. Follow up of benign lesions that have not been subjected 
biopsy.  
10. As a screening test for Carcinoma breast adjunctive to 
mammography.  
THE ADVANTAGES OF ULTRASONOGRAM  
1. Absence of Radiation and its complications.  
2. Can evaluate the lesion and describe details of size, shape, 
echogenicity and relation to surrounding tissues as against 
mammography that gives a result of a density which has less 
specificity. 
3. Ultrasound guided biopsy was found to be more accurate in 
studies than conventional methods and since the biopsy needle 
is seen through the lesion it aids in accurate sample and boosts 
confidence of the operator. 
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4. In preoperative stages mammography is more time consuming 
and the positioning is cumbersome and the results are less 
accurate, hence ultrasonography is better for immediate 
preoperative guidance. 
5. USG gives findings in surgically altered breasts compared to 
mammography. 
6. USG is superior for the imaging of extra capsular rupture of 
prosthesis which cannot be diagnosed by mammography. 
7. In follow-up of benign nodules which are not excised, 
mammography is associated with risk of radiation and 
malignant transformation; hence USG is the investigation of 
choice. 
 
LIMITATIONS OF ULTRASOUND  
1. Less accurate in larger and dense breasts, but highly sensitive in 
compare to mammography. 
2. Less accurate in small (< 1cm) lesions. 
3. Cannot be used as routine for postoperative cases. 
4. Has less sensitivity for the detection of non palpable malignant 
lesions.  
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5. Microcalcifications are not clearly detected as in 
mammography. 
6. Has high false positive rates compared to mammography, it 
classifies many benign lesions as malignant 
 
CYTOPATHOLOGICAL DIAGNOSIS 
Fine Needle Aspiration Cytology 
The development of the needle aspiration technique for diagnosis was 
reported as early as 1847 when Kun described a novel method for diagnosis 
of tumors. In 1883 Leydon aspirated and isolated pneumonic organisms 
using needle aspiration, later in 1904 cervical lymph nodes were subjected to 
needle aspiration by Greig and Gray for the identification of 
trypanosomiasis13. 
Initially larger bore needles were used for aspiration from a variety of 
lesions of lymph nodes; breast, thyroid and prostate, as time passed by 
smaller needles were used, in the recent times needles of 1mm or thinner are 
used for FNAC.14, 15 
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FNAC did not gain much importance till the 1960s and remained a 
controversial topic; only after 1960s it gradually gained the confidence of 
surgeons.10, 16 
European scientists in the Stockholm Karolinska institute in 1960s 
pioneered the use of fine needle aspiration techniques and developed 
protocols for diagnosis and interpretation criteria.10, 16 
Recent developments in FNAC technique and cytological diagnosis 
have propelled its use in multiple sectors and it has developed to be as 
accurate as excision biopsy. 
The advantages of FNAC are that it is an outpatient procedure, does 
not require anesthesia, cost effective and helps adequate preoperative 
planning. 
FNAC technique  
Definition:  FNAC is defined as the study of cells obtained using a 
thin bore or fine needle with negative pressure. The needle aspirate 
specimen contains a minimal quantity of tissue along with fluid. FNAC can 
be used for both superficial and deep masses.17 
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FNAC Personnel  
In western countries the surgeon experienced in doing FNAC does the 
aspiration and the Pathologist interprets it, in our country both aspiration and 
interpretation are done by the pathologists. Adequate skill is necessary for 
both sample acquisition and interpretation.18 
Equipment required 
The equipments required are 1. Needles-23 G disposable needles. 2. 
Syringes –Disposable BD plastic regular 10 ml syringes. 3. Slides-2 or 3 
labeled clean non contaminated sterile slides for smear preparation. 4. 
Alcohol 95% as fixative. 5. Stains- Hematoxylin and Eosin stain, Special 
stains as required by pathologists.19 
Technique 
FNAC is usually a painless procedure, after proper explanation to 
patients, the lesion is held firmly in between the fingers of the examiner and 
the skin is stretched and made taut, the area is properly sterilized and wiped 
clear.68,69 
The needle is attached to the syringe with the plunger in fully closed 
position without air inside the barrel and the needle is introduced into the 
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skin overlying the lesion, the needle is inserted as to feel the anterior edge of 
the lump and after entering it firm negative pressure is applied to the piston 
using a syringe holder or the thumb. 
Several passes are made through the lesion in different angles and 
rotation of the syringe without withdrawing it fully until a small amount of 
fluid is seen in the hub of the syringe. Negative pressure is then released and 
needle withdrawn. 
If the aspirate is more than expected or hemorrhagic is advisable to 
interrupt the procedure and try it from a different angle or do it in another 
session. If tissue is not obtained adequately due to needle blockage the 
needles can be changed and re aspiration done. Breast lumps are usually 
deeper than they appear and sometimes longer needles may be necessary. 
After this slides are smeared with aspirate, fixed with 95% alcohol 
and stained with hematoxylin and eosin stain.20 
 
 
 
 
47 
 
FNAC CYTODIAGNOSTIC CRITERIA 12 
There are 4 categories of breast FNAC cytology19, 20, 21 
1. Inadequate or Unsatisfactory cytology- Here the cell elements 
are inadequate or absent. There has not been a standard criteria 
established for  a diagnostic FNAC aspirate, but each field 
should contain 3 to 6 epithelial cells and should not be obscured 
by blood or other cells. Unsatisfactory smears are due to air 
drying artifacts or due to minimal cellularity of lesion. 
2. No Malignant cells seen –No malignant cells seen, only benign 
cells seen. Benign cells of breast are duct epithelium, apocrine 
cells, RBCs, adipocytes and degenerative nuclei. The nature of 
benign lesion may also be qualified. 
3. Malignant cells present- The report is given as malignancy 
positive only when cells confirmatory of malignancy are 
undoubtedly present and it also should provide information on 
the degree of differentiation and the type of malignancy, but it 
cannot provide details of invasion of surrounding tissues. 
4.  Presence of suspicious cells but not diagnostic of malignancy- 
further histopathological biopsy is to be planned in this group. 
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Differences between benign and malignant cytology22, 23 
Benign  Malignant  
Cell size – Normal  Cell size – Varying usually large  
Adhesion of cells good  Loss of adhesiveness 
Uniformity of cells present Cells are pleomorhic 
Regular but coarse cells Finer appearance , pale cells, 
large nucleoli with intranuclear 
edema 
Cellularity is low  Cellularity is high  
Stripped nuclei are seen  Lack of stripped nuclei 
Nuclear membrane is smooth Nuclear membrane irregular 
Sentinel cells seen  Absence of sentinel cells 
 
 
 
 
Figure 3 - FNAC TECHNIQUE 
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FNAC - CYTOLOGY IMAGES 
 
 
 
 
 
 BENIGN                                                MILDLY ATYPICAL  
  
 
 
 
 
              
                 MARKEDLY ATYPICAL                                       MALIGNANT  
 (SUSPICIOUS) 
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HISTOPATHOLOGICAL DIAGNOSIS 
Biopsy of breast lump 
“Bio” is life and “Opsis” is vision so biopsy means visualization of 
the surgically excised specimen both macroscopically and microscopically. 
Ernest Henri Besnier a French dermatologist coined the word biopsy 
in 1879.Even earlier Rudolph Virchow had explained the fundamentals of 
this procedure and now it has become in indispensable tool in surgical 
practice9.Biopsy and the Histopathology is the ultimate gold standard truth 
for the surgeon, and treatments of lesions either benign or malignant greatly 
rely upon histopathological diagnosis.40 
In this context excision biopsy of breast lesions and its histopathology 
remains gold standard for the diagnosis of malignancy.40. Aspiration 
cytology provides cytopathological diagnosis, whereas biopsy provides 
histopathological diagnosis10. 
Different types of biopsy are available they are 
 Incision biopsy  
 Excision biopsy  
51 
 
 Trucut biopsy  
 Intra ductal biopsy  
 Slide biopsy smears of nipple secretion  
 Superficial biopsy of lesions of the nipple  
Incision biopsy 
Incising the lesion and sending a small amount of tissue is preferred 
by some surgeons for detection of malignancy, it is usually carried out as a 
preliminary procedure before definitive surgery; Incision biopsy and frozen 
section have good accuracy for the detection of malignancy except papillary 
carcinoma of the breast which may be mistaken for papilloma. 
Incision biopsy is usually used to remove a portion of tissue from 
large tumours in which needle biopsy is inadequate. 
Excision Biopsy 
Excision biopsy involves excising the whole tumour in an operating 
room under anaesthesia , if performed adequately with good clearance of 
margins it is both a therapeutic and diagnostic modality. 
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  Excision biopsy and histopathology is the ultimate gold standard for 
breast mass evaluation, it is usually done when imaging or tissue 
investigations are inconclusive or equivocal. 
With advances in FNAC techniques and combination triple 
investigation, the use of excision biopsy is on the decline.  
Trocar or Trucut biopsy 
Small cores of tissue are removed from the breast lesions using small 
hollow trephines or trocars , it helps to obtain tissue for histopathology. 
This technique was first used by Vim Silverman in 1938 and a good trocar 
or trephine biopsy should provide an adequate representational specimen 
But the disadvantages are that they provide only a minimal amount of tissue, 
it cannot provide details about margins and invasiveness of tumour and they 
may miss small lesions. 
 In recent era Ultrasonographic guided trocar biopsy has improved the 
accuracy of this test. 
Intraductal biopsy 
Dilators, small loops and curettes are used to dilate the ducts and 
obtain biopsy specimen from the breast11. 
Biopsies may also be obtained from Nipple smears and surface of 
nipple12.  
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HISTOPATHOLOGY SLIDES 
  
 
 
 
                NORMAL BREAST                                        FIBROADENOMA 
                           
 
  
 
           LOBULAR CARCINOMA                     COMEDOCARCINOMA 
 
          
  
              
             SCHIRROUS CARCINOMA                        DUCTAL CARCINOMA 
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THE MODIFIED TRIPLE TEST 
Previously in the early era of diagnosis open biopsy was done for the 
detection of malignancy, in mid 1970's a triple test consisting of clinical 
examination, mammography and FNAC was introduced which improved 
diagnosis of breast cancer, later mammography was substituted by 
ultrasonogram of the breast and this was called as the modified triple test, if 
these three modalities had a similar correlation then the accuracy of 
diagnosis was about 99%. Even in lesions that are not palpable the 
diagnostic yield is similar to palpable lesion when the triple test is used.33, 34  
Few years ago frozen section after excision was used to confirm the 
diagnosis of breast carcinoma but now preoperative detection of malignancy 
has been facilitated by using cytological tests such as testing the nipple 
discharge or using fine needle aspiration cytology tests from the lumps.  
Making a definitive preoperative diagnosis is very vital because it 
helps to plan surgical decisions. It can avoid unnecessary radical dissections.  
If malignancy is detected by triple test, curative surgery can be planned 
earlier thereby avoiding two surgeries, one for biopsy and other for curative 
treatment.67 
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In recent days treatment of Carcinoma breast is patient centric and 
patient themselves are involved in the process of deciding about the mode of 
surgery and this needs earlier planning so the detection of metastasis and the 
type of lesion become very important.  
Few years ago it was stated in medical literature that every breast 
lump should be excised but this has now been emphasized as every breast 
lump should be assessed and clarified, so assessment includes the triple test 
and its variants, so this test assumes a vital proportion in workup for cancer 
breast.66 
Origin of triple test  
 In his 1987 article Hermansen et al used the term  triple test in breast 
cancer which includes physical examination, mammography and Fine needle 
aspiration of breast mass , about 650 women with breast tumors  were 
studied and the conclusion given was triple test had a accuracy of diagnosis 
similar to that of histological examination. 24 
In another study done by Hardy et al 143 patient with breast masses 
where assessed by several modalities which included mammography, 
ultrasound examination of breast , Magnetic resonance imaging of the breast 
and Fine needle cytology and the conclusion was that the combination of 
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cytology and ultrasound imaging of the breast had the most accurate 
diagnosing power for malignant lesions.25  
In another study done by Lawrence N Bassett et al about 1016 women 
of age 35 years or less presenting with a palpable breast lump were studied 
over a eight year period, in this study it was shown that mammography was 
less sensitive when compared to sonography in the detection of breast 
masses and the benefit of ultrasound was to avoid unwanted biopsy 
procedures , so ultrasound of breast was found to be a preferable mode of 
examination of younger women with breast lumps, but ultrasound was less 
sensitive in detecting very small lumps and could not differentiate benign 
from malignant in smaller lesions.26  
A study done by Vetto et al included fifty five young women with 
palpable breast mass and the value of the Triple test was appreciated, it had a 
negative predictive value and a specificity of 100 % for the detection of 
malignant lesion in younger women when compared to conventional 
excision biopsy, thereby reducing the economic burden on the healthcare 
system and the patient.27  
In another study done by Purasri et al used four tests instead of three 
and included physical examination, FNAC, mammography and 
ultrasonography of breast in 603 young women with palpable breast lumps 
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and put forth a novel scoring system which had an accuracy of 98% in 
detecting malignant lesions.26 
 In a study done by Hatada et al biopsy specimens of 114 malignant 
breast lumps were examined and retrospective analysis of the method of 
cytological analysis was made, in this they found out that USG guided 
FNAC was more accurate (86%) than plain FNAC (65%) in the diagnosis of 
malignant breast lumps, and the results were more pronounced in smaller 
lesions of size <2cm.28  
In a office based ultrasound study done in 660 women by Heiken et al 
brought to light that about 75% of the suspicious lesions detected by USG 
were found to be malignant and only 5% of the lesions described as 
fibroadenaoma turned out to be malignant, this study shows that USG of the 
breast is a valuable screening tool for detection of malignancy.19  
In other study, women with age of less than 35 years presenting with a 
high risk history, breast symptoms and indeterminate findings on 
mammography were studied by Jill S Montrey et al and Ultrasound 
examination of breast was found to have accurate diagnostic power for the 
detection of malignancy.29 
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MATERIALS AND METHODS 
TYPE OF STUDY  
Prospective observational study. 
STUDY CENTRE  
Department of General Surgery, Coimbatore Medical College 
Hospital, Coimbatore. 
PERIOD OF STUDY  
From July 2016 to June 2017 – 1 Year. 
PATIENT POPULATION  
103 consecutive patients presenting to the outpatient and Inpatient 
department of the Department of General surgery, Coimbatore Medical 
College with complaints of a palpable breast mass were included in this 
study. 
INCLUSION CRITERIA 
1. Female patients with age of > 20 years with palpable Breast 
lump 
2. Patient willing for lump excision  
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 EXCLUSION CRITERIA 
1. Patients who are below 20 years. 
2. Male patients  
3.Female patients with advanced disease which makes the 
diagnosis obvious  
4. Patients not willing for lump excision 
The study was conducted after obtaining permission from the 
Institutional Ethics Committee. The patients were clearly explained about 
the nature of study and its implications and an informed written consent was 
obtained from the patients after explaining the procedure in their vernacular 
language. 
COLLECTION AND ACCUMULATION OF DATA  
The patients were enrolled in the study after applying the inclusion 
and the exclusion criteria.  A detailed History regarding the complaints, the 
mode of presentation, site of lump and associated symptoms was obtained, a 
complete physical examination and examination of the breast and the mass 
was made. Each patient underwent a modified triple test which included a 
complete clinical examination, next was the ultrasound examination of the 
breast mass and finally Fine Needle aspiration of the breast lump was made. 
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Based on each test the palpable breast lumps were classified as 
benign, malignant or inconclusive. 
Malignant lesions 
These lesions are ill defined. These are hard in consistency with 
angulated and abrupt borders and microcalcification seen in Ultrasound 
examination. 
Benign Lesions 
These lesions may be cystic lesions or solid lesions. 
Cysts are oval or round with clearly defined margins and they are not 
echogenic, these cysts may be simple cysts with through and through 
transmission of echoes or may be abscesses with septations and internal 
echogenicity. 
Solid benign lesions may be fibroadenomas which may be lobulated 
with single to several lobulations, rounded or oval in shape and covered by a 
pseudo capsule and has uniform homogenous echo pattern in Ultrasound. 
Fibrodenosis is a condition in which there is increase in fibrous and 
glandular elements of the breast not confined to any area sometimes there 
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may be certain cystic areas with increased echogenicity and the architecture 
of the breast is maintained. 
Breast Examination included examination of the breast, the axilla on 
both sides, both supraclavicular fossa and all lymph node areas were 
examined to rule out generalized lymphadenopathy. 
Ultrasound examination of breast  
Ultrasound examination of the breast was done using a high frequency 
linear transducer (7.5 to 10 megahertz) in the department of Radiology, 
Coimbatore Medical College Hospital, Coimbatore by an experienced 
radiologist well versed with radiological examination of the breast and the 
patients were examined in supine position and scanning of the breast was 
done horizontally and vertically, Ultrasound examination of both breasts, 
axillary region and supraclavicular lymph nodes was also done.  
Fine needle aspiration cytology  
FNAC was done by a pathologist and aspiration was done using a 22- 
23 gauge needle attached to a 10 ml syringe with the patient in supine 
position and the ipsilateral upper limb raised beside the head, the lesion was 
fixed with one hand and the biopsy needle was inserted into the lump and 
moved  back and forth into the mass several times , while constant negative 
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suction was maintained until aspirate was seen at the hub of the needle , then 
suction was released and the needle withdrawn and the material was spread 
on three slides, then taken up for cytological examination after fixation and 
staining.  
The results were reported as benign, malignant or indeterminate.  
Histopathological examination  
All the patients had some form of surgery based on the result of the 
modified triple test, patients with benign lesions had excision biopsy and 
malignant lesions had Modified Radical Mastectomy, the surgical specimens 
were examined in the pathology department and the results were classified 
as benign or malignant.  
Analysis and interpretation of data  
The particulars in the pro forma were tabulated in Microsoft excel 
program and statistical analysis was done using SPSS software system and 
appropriate statistical tests were used as necessary and various parameters 
were analyzed and result of the modified triple test were analyzed 
individually and collectively, finally the result was compared to 
Histopathological diagnosis. 
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Fine Needle aspiration Cytology was reported and tabulated as follows:  
a. Inadequate material - The aspirate had poor cellular content and 
was not sufficient for cell type assessment. 
 b. Benign cytology – Adequate aspirate with benign appearing 
cells indicating the diagnosis of fibrocystic disease of breast or 
a Fibroadenoma.   
 c. Atypical cell cytology – Minimal atypia; which was interpreted 
as benign breast lesion. 
 d. Suspicious cytology - Malignancy – suspect cells with features 
of malignancy and non interpretable cytology. 
The interpretation of results was done as follows  
 Repeat cytology  
 Benign lesion  
 Malignant lesion  
 Inconclusive test  
The patients with benign and inconclusive lesions underwent an 
excision biopsy and the patients with report as malignancy were subjected to 
modified radical mastectomy, the excision biopsy and mastectomy 
specimens were subjected to histopathology examination and the results 
were recorded and compared to the results of the Modified triple test. 
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RESULTS AND OBSERVATIONS 
After application of inclusion and exclusion criteria 103 female 
patients were included for the study. 
AGE DISTRIBUTION 
AGE (IN YEARS) NO OF PATIENTS PERCENTAGE 
21-30 24 23.20% 
31-40 47 45.60% 
41-50 23 22.30% 
51-60 6 5.80% 
>60 3 3.10% 
 
 
Out of the 103 patients 24 patients were between the age group of 21 
to 30 years (23.20%), 47 patients were in the age group of 31 to 40 years 
(45.60%), 23 patients were in the age group of 41 to 50 years (22.30%), 6 
patients were in the age group of 51 to 60 years (5.8%), 3 patients were 
above the age of 60 years (3.10%). 
23%
46%
22%
6% 3%
AGE DISTRIBUTION 
21 -30
31 -40
41 -50
51 -60
> 60
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DURATION OF SYMPTOMS 
DURATION OF 
SYMPTOMS 
NO OF 
PATIENTS 
PERCENTAG
E 
< 3 MONTHS 16 15.50% 
4-6 MONTHS 61 59.20% 
7-9 MONTHS 22 21.40% 
> 9 MONTHS 4 3.90% 
 
 
Most of the patients 61 out of 103 patients (59.2%) had symptoms for 
the duration of 4 to 9 months, and only 4 patients out of 103 had symptoms 
for more than 9 months (3.9%). 
16
61
22
4
<  3  M O N T H S 4 - 6  M O N T H S 7 - 9  M O N T H S >  9  M O N T H S
DURATION OF SYMPTOMS
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PAIN OVER LUMP 
 
PAIN OVER LUMP NO OF PATIENTS PERCENTAGE 
YES 53 51.50% 
NO 50 48.50% 
 
 
 
  
 
 
53
50
48.5 49 49.5 50 50.5 51 51.5 52 52.5 53 53.5
YES
NO
PAIN OVER LUMP
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NIPPLE DISCHARGE 
 
NIPPLE DISCHARGE NO OF PATIENTS PERCENTAGE 
PRESENT 22 21.30% 
ABSENT 81 78.70% 
 
 
 
 
 
 
PRESENT, 22
ABSENT, 81
NIPPLE DISCHARGE
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QUADRANT INVOLVED 
QUADRANT INVOLVED NO OF PATIENTS PERCENTAGE 
LOWER INNER 9 8.70% 
LOWER OUTER 24 23.30% 
UPPER INNER 23 22.40% 
UPPER OUTER 47 45.60% 
 
 
 
Upper outer quadrant of the breast was found to be most commonly 
involved with tumor, 47 out of 103 patients (45.6%) with least involvement 
seen in the lower inner quadrant, 9 out of 103 patients (8.7%). 
LOWER INNER, 
9
LOWER OUTER, 
24
UPPER INNER, 
23
UPPER OUTER, 
47
QUADRANT INVOLVED
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LUMP SIZE 
MAXIMUM LUMP SIZE NO OF PATIENTS PERCENTAGE 
2 CM 11 10.70% 
2.5 CM 11 10.70% 
3 CM 47 45.60% 
3.5 CM 2 1.94% 
4 CM 23 22.40% 
4.5 CM 1 0.97% 
5 CM 8 7.69% 
 
 
A lump size of 3 to 4 cm in maximal diameter was found in 72 out of 
103 patients (69%). 
11 11
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CONSISTENCY 
CONSISTENCY NO OF PATIENTS PERCENTAGE 
FIRM 61 59.20% 
HARD 39 37.90% 
FIRM TO HARD 3 2.90% 
 
 
 
61 out of 103 patients had lumps which were firm in consistency 
(59.2%) and 39 out of 103 patients had lesions which were hard in 
consistency.  
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AXILLARY NODAL STATUS 
 
AXILLARY NODE 
INVOLVEMENT 
NO OF PATIENTS PERCENTAGE 
PRESENT 21 20.40% 
ABSENT 82 79.60% 
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USG FINDINGS 
USG FINDING NO OF PATIENTS PERCENTAGE 
BENIGN 60 58.20% 
MALIGNANT 33 32% 
INCONCLUSIVE 10 9.80% 
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FNAC 
 
FNAC NO OF PATIENTS PERCENTAGE 
BENIGN 60 58.20% 
MALIGNANT 35 34% 
INCONCLUSIVE 8 7.80% 
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SURGICAL METHOD 
 
SURGICAL METHOD NO OF PATIENTS PERCENTAGE 
EXCISION 68 66% 
MRM 30 29.10% 
BCS 5 4.90% 
 
 
All the 103 patients included in study were subjected to some form of 
surgery like Excision biopsy, Breast conservation surgery (BCS), or 
Modified Radical Mastectomy (MRM). 68 patients were subjected to 
Excision biopsy. 5 patients (4.90%) were treated with BCS as they were 
eligible for the same. 30 patients (29.10%) underwent Modified Radical 
Mastectomy.  
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HISTOPATHOLOGY 
 
HISTOPATHOLOGY NO OF PATIENTS PERCENTAGE 
BENIGN 65 63.10% 
MALIGNANT 38 36.90% 
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NIPPLE DISCHARGE 
 
HISTOPATHOLOGY 
NIPPLE DISCHARGE MALIGNANT BENIGN 
PRESENT 17 5 
ABSENT 21 60 
P VALUE - 0.001 
SIGNIFICANT 
CHI SQUARE TEST 
 
 
22 patients out of the total 103 patients presented with nipple 
discharge (21.3%), of them 17 were found to have malignancy (77%). 
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PAIN OVER LUMP 
 
HISTOPATHOLOGY 
PAIN OVER LUMP MALIGNANT BENIGN 
YES 8 45 
NO 30 20 
P VALUE - 0.002 
SIGNIFICANT 
CHI SQUARE TEST 
 
 
53 out of the 103 patients had pain over the lump , of them 8 
patients(15%) were found to have malignant disease , 30 patients out of 50 
patients (60%) patients with painless lump had malignancies. 
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AXILLARY NODE INVOLVEMENT 
 
 
HISTOPATHOLOGY 
AXILLARY NODE INVOLVEMENT MALIGNANT BENIGN 
YES 19 2 
NO 19 63 
P VALUE - 0.001 
SIGNIFICANT 
CHI SQUARE TEST 
 
 
21 out of 103 patients (20.4%) had axillary node involvement, out of 
the 21 patients 19 had biopsy proven malignancy (90%). 
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INCIDENCE OF MALIGNANT DISEASES 
MALIGNANT 
NO OF 
PATIENTS 
PERCENT
AGE 
(N = 103) 
PERCENT
AGE 
(N=38) 
INVASIVE DUCTAL 
CARCINOMA 
29 28.10% 76.30% 
DUCTAL CARCINOMA IN 
SITU 
3 2.90% 7.80% 
INVASIVE LOBULAR 
CARCINOMA 1 0.97% 2.65% 
INFLAMMATORY 
BREAST CA 
1 0.97% 2.65% 
INVASIVE PAPILLARY 
NEOPLASM 
2 1.94% 5.30% 
MUCINOUS CARCINOMA 2 1.94% 5.30% 
 
38 patients out of 103 had biopsy proven malignancy. Of the 
malignancies proven by histopathology (38 patients) , 29 patients had 
invasive ductal carcinoma (76.3%), 3 patients(7.8%) had ductal carcinoma 
insitu ,2 patients(5.3%) had invasive papillary neoplasm, 2 patients 
(5.3%)had mucinous carcinoma, 1 patient (2.65%) had invasive lobular 
carcinoma, 1 patient(2.65%) had inflammatory carcinoma of breast. 
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INCIDENCE OF BENIGN DISEASES 
BENIGN(N=65) 
NO OF 
PATIENTS 
PERCENT
AGE 
(N=103) 
PERCENT
AGE 
(N=65) 
FIBROADENOMA 35 33.90% 53.80% 
BREAST ABCESS 2 1.94% 3% 
BENIGN PHYLLOIDES 7 6.80% 10.80% 
FIBROCYSTIC DISEASE 17 16.50% 26.40% 
INTRADUCTAL 
PAPILLOMA 1 0.97% 1.50% 
MULTIPLE INTRADUCTAL 
PAPILLOMA 
2 1.94% 3% 
TUBULAR ADENOSIS 1 0.97% 1.50% 
 
65 out of 103 patients had benign lesions as seen by histopathology. 
Fibroadenoma was the most common benign breast tumour, seen in 35 out 
of 65 patients (53.8%), next common benign lesion was fibrocystic disease 
which was seen in 17 out of the 65 patients (26.4%).7 patients (10.8%) 
patients had benign phyllodes tumour,multiple intraductal papilloma was 
seen in 2 patients(3%).Breast abscess was found in 2 patients(3%).Solitary 
intraductal papilloma was seen in 1 patient (1.5%).Tubular adenosis was 
seen in 1 patient(1.5%). 
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ULTRASONOGRAM 
 
HPE 
USG FINDING MALIGNANT BENIGN 
MALIGNANT 33 0 
BENIGN 0 60 
INCONCLUSIVE 5 5 
P VALUE - 0.001 
SIGNIFICANT 
 
 
USG FINDING 
SENSITIVITY 86.84% 
SPECIFICITY 100% 
POSITIVE PREDICTIVE VALUE 100% 
NEGATIVE PREDICTIVE VALUE 92.86% 
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60 patients out of 103 (58.2%) had Ultrasound features suggestive of 
Benign breast lumps and 33 out of 103(32%) had features of malignancy, 10 
(9.8%) patients out of 103 had inconclusive features. Of the 
ultrasonographically suggested benign disease all of them had benign 
disease by histopathology and all the Ultrasonographically suspected 
malignant lesions were proven by biopsy to be malignant, of the remaining 
10 inconclusive lesions by ultrasound 50% were found to have malignant 
disease. 
Sensitivity and specificity of ultra sonogram for the detection of 
Malignancy was 86.84 % and 100 % respectively.Positive predictive value 
for detection of malignancy was 100%, Negative predictive value to rule out 
malignancy was 92.86%. 
CLINICAL EXAMINATION 
 
HPE 
CLINICAL EXAMINATION MALIGNANT BENIGN 
MALIGNANT(HARD) 33 6 
BENIGN(FIRM) 2 59 
INCONCLUSIVE(FIRM TO HARD) 3 0 
P VALUE - 0.001 
SIGNIFICANT 
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CLINICAL EXAMINATION FINDING 
SENSITIVITY 86.34% 
SPECIFICITY 91% 
POSITIVE PREDICTIVE VALUE 85% 
NEGATIVE PREDICTIVE VALUE 92.19% 
 
33 out of 39 (85%) patients with hard lumps which were clinically 
suggested as malignant turned out to be malignant, whereas 6 patients with 
hard lumps had benign disease (15%), 61 patients out of 103 had lumps with 
firm consistency suggestive of benign lesions of them 2 had malignancy 
(3.2%).3 patients had lumps with firm to hard in consistency of which all of 
them were malignant.Clinical examination had a sensitivity of 86.34 % and 
specificity of 91% for the detection of malignancy. Positive predictive value 
of Clinical examination was 85% and Negative predictive value was 
92.19%. 
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FINE NEEDLE ASPIRATION CYTOLOGY 
 
HPE 
FNAC MALIGNANT BENIGN 
MALIGNANT 35 0 
BENIGN 1 59 
INCONCLUSIVE 2 6 
P VALUE - 0.001 
SIGNIFICANT 
 
 
FNAC FINDING 
SENSITIVITY 92.10% 
SPECIFICITY 100% 
POSITIVE PREDICTIVE VALUE 100% 
NEGATIVE PREDICTIVE VALUE 95.58% 
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According to Fine Needle Aspiration Cytology report, 60 patients out 
of 103 (58.2%) were diagnosed to have benign breast disease, whereas 35 
patients (34%) were diagnosed to have malignant disease. 8 (7.8%) patients 
had inconclusive reports.All patients with FNAC report suggestive of 
malignancy were biopsy proven to have carcinoma. But 1 out of 60 patients 
(1.6%) who were reported to have benign disease had malignant disease. 
Here the FNAC report was fibrocystic disease of breast and the biopsy 
report turned out to have invasive papillary carcinoma.2 patients out of 
8(25%) who had inconclusive FNAC reports had malignancy in biopsy 
specimen. Of them 1 patient’s FNAC report was proliferative breast disease 
with atypia and other one’s was atypical ductal hyperplasia. Both of them 
had invasive ductal carcinoma. 
Sensitivity and specificity of Fine Needle Aspiration Cytology to 
detect malignancy were 92.10% and 100% respectively. Positive predictive 
value was 100% and Negative predictive value was 95.58%. 
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MODIFIED TRIPLE TEST 
 
HPE 
MTT MALIGNANT BENIGN 
MALIGNANT 37 0 
BENIGN 1 65 
P VALUE - 0.001 
SIGNIFICANT 
 
 
MTT FINDING 
SENSITIVITY 97.36% 
SPECIFICITY 100% 
POSITIVE PREDICTIVE VALUE 100% 
NEGATIVE PREDICTIVE VALUE 98.48% 
All 103 patients included in the study were subjected to Modified 
Triple Test (MTT) and of them 37 patients (36%) had features suggestive of 
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malignant disease and 66 patients (64%) were suspected to have benign 
breast disease. All 37 patients suspected to have malignancy on Modified 
Triple Test were biopsy proven to have malignant breast disease, where as 1 
out of 66(1.5%) patients assigned to have benign disease on Modified Triple 
Test  turned out to be malignant. 
The sensitivity of modified triple test for the detection of malignancy 
was 97.36% and the specificity for the detection of malignancy was 
100%.The positive predictive value of the Modified triple test was 100% and 
the Negative predictive value was 98.4%.Thus Modified Triple test was 
demonstrated to be a very efficient screening test for the detection of breast 
malignancies in palpable lumps. 
COMPARISON OF ALL METHODS 
 
C/E USG FNAC MTT 
SENSITIVITY 86.34% 86.84% 92.10% 97.36% 
SPECIFICITY 91% 100% 100% 100% 
POSITIVE PREDICTIVE VALUE 85% 100% 100% 100% 
NEGATIVE PREDICTIVE VALUE 84.42% 92.86% 95.58% 98.48% 
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DISCUSSION 
Breast lumps are one of the commonest findings in women attending 
surgical clinics, presence of a lump invokes a sense of fear and insecurity 
among these women and all the lumps are believed to be malignant, since 
breast malignancy is very much amenable to curative treatment when 
detected early, so it becomes essential that malignancy is detected at earlier 
stages to allay fear and institute early treatment. 
Multimodal investigations are therefore used for the preoperative 
detection of malignancy.65 
Of these tests the triple test consisting of Clinical examination, 
mammography and Fine needle aspiration cytology has been used with fairly 
accurate results and the modification of this test using ultra sonogram of 
breast instead of mammogram has been used for the early detection of 
malignancy and is evaluated in our study.  
The primary aim of this modified triple test is to make an accurate 
preoperative diagnosis, thereby avoiding unnecessary surgeries in case of a 
benign breast lump.  
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Our study tries to evaluate the efficiency of the modified triple test 
(i.e. Clinical Breast examination, Ultrasound of breast and FNAC) as 
isolated tests and as a combination for the detection of malignancy, in this 
study Histopathological examination of the breast lump was used as the 
reference standard for comparison. 
In a retrospective study done by Gobler et al 207 patients with 
palpable breast masses were examined and it was concluded that if the result 
of combined evaluation consisting of a triple test of clinical examination, 
mammography and cytology were concordant, a diagnostic accuracy was 
100 % and with discordant results 75% of masses were malignant. Gobler 
arrived at a conclusion that preliminary surgical biopsy and frozen section of 
the lesion may not be all that necessary when the triple test unequivocally 
identifies malignancy.35 
In a systematic review of 15 studies in which the triple test was used 
for the diagnosis of palpable breast lumps, a combination of the three tests is 
consistently more sensitive than a single test, and the capability of 
identifying malignancy approaches 95 to 100 % when at least one 
component of the triple test is positive. When all the components of the 
triple test are in agreement, the probability that the diagnosis is right is 
approximately 99% whether it is positive or negative diagnosis.36 
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This has given us an information that the triple test and its 
modifications is a dependable, feasible and accurate test for the diagnosis 
and treatment of palpable breast lumps, and its efficiency is equivalent to 
open biopsy and it has the advantages of less cost and time and single visit, 
it also helps us to prevent unnecessary surgical procedures thereby reducing 
morbidity.  
The triple test is an accurate test if done by experienced operators and 
if the results are assessed correctly. 
In a prospective study involving 200 women with palpable breast 
tumours using the triple test done by Crone et al clinical examination, 
mammography and FNAC was done and the results were analyzed alone and 
in combinations, all the tumours were subjected to excision biopsy, out of 
the 200 lesions 38 lesions were found to be malignant. In this test even 
though the triple test was found to be accurate there was a statistical 
possibility of overlooking  a few malignant lesions , so it was concluded that 
all the palpable breast lumps should be excised.37 
The same point was emphasized by Donegan and Dennis who 
believed that a solid breast mass always requires a firm diagnosis and should 
be excised for histological diagnosis.38, 39 
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Jin Young Kwak, et al in a 2006 study investigated the application of 
the Breast Imaging Reporting and Data System Final Assessment System in 
Sonography of Palpable Breast Lesions and Reconsideration of the Modified 
Triple Test in this study they followed up 160 palpable breast lesions and 
subjected the lesions to palpation-guided FNAC, targeted sonography, and 
then histopathologic confirmation was done. It was shown in this study that 
Ultrasonography of breast was as accurate as palpation guided Fine needle 
aspiration for not missing the diagnosis of malignancy.41 
In a study done in 55 young women with palpable breast lumps done 
by Vetto et al, the Modified triple test was used and it was shown to have a 
high diagnostic accuracy for the detection and differentiation of malignancy. 
Thereby it suggested that the modified triple test helps to avoid unwanted 
surgery and also is cost effective. 42 
A large multicenter study supported by the Avon Foundation and the 
National Institutes of Health was created through the American College of 
Radiology Imaging Network. In this project, a protocol to assess the efficacy 
of screening breast ultrasound was implemented in 14 imaging centers to 
better define the role of US in breast cancer screening. The study reported 
higher cancer detection in high-risk women that underwent annual 
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ultrasound screening in addition to mammography compared to those that 
underwent mammography alone. 43 
The first ultrasound system was approved in 2012 by the US FDA for 
the screening of breast cancer in conjunction with mammography, especially 
for women with dense breast tissue and was also indicated in women with a 
negative mammogram, no symptoms of cancer breast and with no prior 
history of biopsy or breast surgery. 
Stavros et al put forth a scheme for classification of breast nodules as 
benign, indeterminate or malignant using Ultrasound findings.44 
In the light of the above information we discuss the results of our 
study, our study was an observational study and 103 patients were subjected 
to the study. In our study breast lumps were commonly seen in the age group 
of 31 to 40 years (45.6%) and least commonly seen after the age of 60 years, 
this is similar to the distribution seen in other studies. Younger aged women 
have more education standards and awareness that lead them to present 
earlier in the course of disease. 
About 59.2% of all the patients had symptoms for 4 to 9 months 
which was similar to that seen in few studies but some studies reported 
shorter duration of symptoms of mean of  3 months (Afsar A Bhatti et al 
2010).45 
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Pain over the lump was an important symptom and 60% of patients 
with painless lumps had malignancy on histopathological examination                  
(30 out of 50) in contrast to 15 % of the patients with painful breast lumps       
(8 out 53).Similar findings were also seen in a study conducted by Kaire 
innos et al (BMC public health 2013) and the usual mode of presentation of 
malignancy was a painless palpable lump.46 
Of the clinical examination findings nipple discharge was also found 
to be an important finding. Of the patients with nipple discharge 77 %                 
( 17 out of 22) were found to have malignancy on final histopathological 
diagnosis, so nipple discharge might serve as an important clue to the 
diagnosis of malignancy, but many studies have shown that nipple discharge 
is usually benign and 10 to 15% of the patients with nipple discharge tend to 
have malignancy.(Van Zee K J et al Cancer 1998), probably study with a 
larger sample size would iron out the skewed results seen in our study.47 
In our study the upper outer quadrant was commonly involved with 
tumor (45.6%) this was also consistent with the findings with a study done 
by Khemka et al., Hussain et al., and Khoda et al (JMS 2015).It has been 
demonstrated that the upper outer quadrant of the breast has more amount of 
epithelial tissue compared to other quadrants leading to more incidence of 
tumors.48, 49, 50 
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Axillary lymph node involvement was seen in 20.4 % (21 out of 103) 
of patients presenting with breast lumps and out of the patients who had 
axillary nodes 90%(19 out of 21) had biopsy proven malignancy, so axillary 
node involvement is a strong predictor that the tumor is malignant, this has 
also been recorded by Voss M et al (J Surg Oncol. 1999). It has been 
concluded in the study that patients with stage 3 breast cancer have a higher 
incidence of axillary metastasis and well differentiated tumors tend to 
metastasize slowly. So axillary involvement may be a pointer towards 
advanced or fast growing malignancy and should prompt immediate 
attention.51 
When the clinical examination findings were examined as a whole 
clinical examination had sensitivity of 86.34 % and specificity of 91% for 
the detection of malignancy. Positive predictive value of Clinical 
examination was 85% and Negative predictive value was 92.19%.  
 On analysis of various studies, it has been shown that sensitivity of 
the Clinical breast examination ranges from 21% to as high as 100% and the 
specificity ranges from 50% to 97.8%. In the present study, the high 
sensitivity could be because only patients with confirmed palpable lumps 
were included for the study. Our results are in concordance with many 
studies. 
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ULTRASONOGRAPHY OF BREAST  
The triple test used mammography as one of its components and 
mammogram had a sensitivity of 87% for malignancy detection. Crystal et al 
(2003), Susan k et al (2005), Corsetti et al (2006) and Sahiner et al (2007) 
had supported the use of USG in young patients with dense breast tissues 
and ultrasound was found to have a sensitivity of 89% in detecting 
symptomatic and palpable breast abnormalities.52-55 
Though relatively a fresh modality ultrasound has gained widespread 
popularity due to easy availability of the equipment, it is less expensive and 
is non invasive and can provide accurate information in tumors more than 
2mm. Both USG and mammography have their inherent advantages and 
disadvantages that have been discussed in literature. But in the current 
scenario USG has gained the acceptance among the medical fraternity and is 
included in the screening for malignant lesions of breast as a part of the 
modified triple test and its results are adequately validated by many studies. 
In our study 33 out of 103 patients had ultrasound findings suggestive 
of malignancy; out of them all had biopsy proven malignancy. Ultrasound 
had a sensitivity of 86.84% and specificity of 100% for the detection of 
malignancy, Positive predictive value for detection of malignancy was 
100%, Negative predictive value to rule out malignancy was 92.86%. 
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These findings when compared to available literature shows good 
correlation and in a study done by Khoda et al, USG sensitivity was 91.6%, 
specificity was 100%, positive predictive value was 100%, negative 
predictive value was 97.3%, Similarly in a study done by Pande et al 
sensitivity, specificity, positive predictive value and negative predictive 
value for ultrasonography were 95%, 94.1%, 95.5%, and 93.7%, 
respectively. Another study by Jan et al also yielded similar results. 50, 56, 57 
A sensitivity of 86.84 % means 13.16 malignant lesions would be 
missed out of 100 malignant lesions, so the diagnosis of a benign lump 
always does not mean that it is benign and it would need a combination of 
tests to confirm it, but nonetheless USG of the breast is a valuable and easy 
tool for the detection of malignancy. 
 
FINE NEEDLE ASPIRATION CYTOLOGY 
In our study Fine Needle aspiration classified, 60 patients out of 103 
(58.2%) as having benign breast disease, whereas 35 patients (34%) were 
diagnosed to have malignant disease. 8 (7.8%) patients had inconclusive 
reports. All patients with FNAC report suggestive of malignancy were 
biopsy proven to have carcinoma. But 1 out of 60 patients (1.6%) who were 
reported to have benign disease had malignant disease. Sensitivity and 
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specificity of Fine Needle Aspiration Cytology to detect malignancy were 
92.10% and 100% respectively. Positive predictive value was 100% and 
Negative predictive value was 95.58%. 
FNAC RESULTS IN VARIOUS STUDIES 58-62 
 
It is shown that the results of our study are comparable to various 
studies and the values closely resemble the results seen by Mohamed et al. 
So the results indicate that FNAC as an independent variable has adequate 
diagnostic power and this is further enhanced by combination with other 2 
tests. 
THE MODIFIED TRIPLE TEST ANALYSIS 
Using modified triple test 37 patients (36%) had features suggestive of 
malignant disease and 66 patients (64%) were suspected to have benign 
breast disease. All of the 37 patients suspected to have malignancy on 
Study Sensitivity % Specificity% Positive 
predictive 
value% 
Negative 
predictive 
value % 
Our study 92.10 100 100 95.58 
Sankaya & 
Dongre 
88.37 96.42 97.43 84.37 
Choi et al 77.70 99.20 97.43 84.37 
Mohammed et al 90.62 100 100 95.08 
Kim et al 94.59 87.91 79.54 97.03 
Park and Ham 76.90 91.60 - - 
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Modified Triple Test were biopsy proven to have malignant breast disease, 
where as 1 out of 66(1.5%) patients assigned to have benign disease on 
Modified Triple Test  turned out to be malignant. The sensitivity of modified 
triple test for the detection of malignancy was 97.36% and the specificity for 
the detection of malignancy was 100%.The positive predictive value of the 
Modified triple test was 100% and the Negative predictive value was 98.4%. 
 
Comparison of Studies Using Modified Triple Test 50,57,63,64 
 
 
This comparison shows that our results were comparable to the results 
seen in many studies and it has shown that the modified triple test can be 
used as a valuable clinical test for the detection of malignant lumps and it 
helps us to plan the surgical treatment earlier, accurately and helps us save 
time needed for a definitive diagnosis. 
 
Study Sensitivity 
% 
Specificity% Positive 
predictive 
value% 
Negative 
predictive 
value % 
Our study  97.36 100 100 98.40 
Baykara et al  100 92.01 53.16 100 
Khoda et all 100 100 100 100 
Jan et al  100 99.3 93.3 100 
Vaithyanathan  
et al  
100 82 76.9 100 
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CONCLUSION 
Breast cancer is the foremost cause of cancer related death in young 
females; hence early detection of breast cancer carries much importance. 
The modified triple test in our study was an accurate predictor of 
malignancy, all of the patients who were suspected to have malignancy by 
Modified triple test had malignancy on histological analysis and specificity 
was 100%, that proved it as a best initial test for diagnosis of malignancy 
preoperatively. 
The results of the modified test in our study are as accurate as 
histological diagnosis. 
Of the three components of the modified triple test FNAC and 
Ultrasound of breast had 100% specificity for the diagnosis of malignant 
lumps.  
The modified triple test can be done in an outpatient clinic and the 
patients are not exposed to ionizing radiation.  So it is a suitable diagnostic 
modality for breast lumps in young women of childbearing age. It has been 
shown that Ultrasound is as accurate as mammography in detection and 
differentiation of palpable breast lumps and it can also aid in guiding the site 
for FNAC and biopsy. 
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Of the three components of the modified triple test FNAC was the 
most accurate modality.  
Three components of the modified triple test complemented each 
other and when done with experienced clinicians and Radiologists can 
reduce the time lag for the detection of malignancy and help us to institute 
early definitive treatment. 
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PROFORMA 
 NAME:       AGE:     SEX: 
 IP NO:        OCCUPATION:  
D.O.A:       D.O.D: 
 
  
  
HISTORY OF PRESENTING 
ILLNESS: 
PAIN 
Duration   
Time and mode of 
onset  
 
Site of pain   
Character of pain   
Radiation   
Aggravating factors   
Relieving factors  
NIPPLE DISCHARGE 
Colour  
Quantity  
 
PERSONAL HISTORY: 
Diet  
Habits   
Bladder & Bowel   
Sleep  
 
 FAMILY HISTORY: 
Marital status  
Similar illness in family  
 
CHIEF COMPLAINTS  
LUMP PAIN NIPPLE DISCHARGE 
NIPPLE 
RETRACTION OTHERS 
PAST HISTORY 
H/O Similar Complaints   
Duration   
Treatment taken   
Previous surgeries  
SHT /DM/TB  
MENSTRUAL HISTORY: 
GENERAL EXAMINATION: 
1. General survey  
2. Body build and nourishment   
3. Appearance  
4. Attitude Restless/ Quiet 
5. Dehydration   Mild/ Moderate/ Severe/ Nil 
6. Anaemia/ Jaundice/ Clubbing/ Cyanosis/ 
Lymphadenopathy/ Pedal oedema  
 
7. Pulse   
8. Temperature  
9. Respiratory rate  
10. Blood pressure  
    
 LOCAL EXAMINATION  
1.INSPECTION  
BREAST  
Position  
    
Size and shape  
 
Any puckering or dimpling Skin over the breast  
 
NIPPLE 
 Position  
Size and shape  
Surface Discharge  
AREOLA  
ARM AND THORAX  
AXILLA AND SUPRACLAVICULAR FOSSA  
2. PALPATION 
Local rise of temperature  
Tenderness  
Situation Size and shape 
 Surface and margin  
Consistency  
Fluctuation 
 Fixity to the skin  
Fixity to the breast tissue 
 Fixity to the underlying fascia and muscles  
Fixity to the chest wall  
Palpation of the nipple 
 EXAMINATION OF LYMPH NODES  
Pectoral group  
Brachial group  
Subscapular group  
Central group  
Apical group Cervical 
 RECTAL EXAMINATION : 
VAGINAL EXAMINATION : 
SYSTEMIC EXAMINATION : 
• Cardiovascular system  
• Respiratory system  
• Central nervous system  
• Genito-urinary system  
 Abdominal examination  
 
 
 
INVESTIGATIONS 
BLOOD INVESTIGATIONS  
Hb  
TC  
DC  
ESR  
BT  
CT  
BLOOD GROUP & Rh type  
Sugar  
Urea  
Creatinine  
 
URINE 
Albumin  
Sugar   
Microscopy  
 
 Chest x-ray  
SEROLOGY 
HIV  
HBSAg  
HCV  
  
DIAGNOSIS: 
MANAGEMENT & SURGICAL NOTES: 
  
 
 
 
 
 
 
 
CONSENT FORM 
 I,     , do hereby volunteer and consent to 
participate in this  study being conducted by Dr.M.SARASWATHY on " A 
STUDY OF PALPABLE BREAST LUMPS WITH EMPHASIS ON 
EARLY DETECTION OF MALIGNANCY USING A MODIFIED 
TRIPLE TEST "I have read and understood the consent form or it has been 
read and explained to me in my own language. The study has been fully 
explained to me and I may ask questions at any time. 
 
Signature / Left Thumb Impression of the Volunteer             Date:                 
Place: 
 
Signature and Name of witness                                             Date:                  
Place: 
 
Signature of the investigator: 
 
Name of the investigator:               
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KEY TO MASTER CHART 
 
USG  -  ULTRASONOGRAM 
FNAC - FINE NEEDLE ASPIRATION CYTOLOGY 
HPE  - HISTO PATHOLOGICAL EXAMINATION 
L  - LEFT 
R  - RIGHT 
Y  - YES 
N  - NO 
UI  - UPPER INNER 
UO  - UPPER OUTER 
LO  - LOWER OUTER 
LI  - LOWER INNER 
F  -  FIRM 
H  - HARD 
B  - BENIGN 
M  - MALIGNANT 
MRM  - MODIFIED RADICAL MASTECTOMY 
BCS  - BREAST CONSERVATION SURGERY 
FA  - FIBRO ADENOMA 
MIDP - MULTIPLE INTRADUCTAL PAPILLOMA 
FCD  - FIBRO CYSTIC DISEASE 
IDC  - INVASIVE DUCTAL CARCINOMA 
IPN  - INVASIVE PAPILLARY NEOPLASM 
PHY  - PHYLLODES 
TUB ADE - TUBULAR ADENOSIS 
DCIS  - DUCTAL CARCINOMA INSITU 
MUC CA - MUCINOUS CARCINOMA 
BA  -  BREAST ABSCESS 
IDP  - INTRA DUCTAL PAPILLOMA 
 
S.No Name Age 
Duration of 
symptoms in 
months 
Side of breast 
Pain over the 
lump
Nipple discharge 
Quadrant 
involved 
Max lump size in 
cm 
Consistency 
Axillary node 
involvement 
USG report FNAC Report
Surgery 
performed 
HPE Report HPE
1 Padmini 38 3 R Y N UI 3 F N B B EXCISION B FA
2 Jothilakshmi 40 5 L N Y UO 4 F N B B EXCISION B MIDP
3 Vanithamani 24 6 L N N UO 3 F N B B EXCISION B FA
4 Meena 30 5 R Y N LO 3 F N B B EXCISION B FA
5 Eswari 46 3 L Y N UI 4 F N B B EXCISION B FA
6 Gayathri 29 7 L Y N UO 3 F N B B EXCISION B FA
7 Mahalakshmi 29 4 R Y N UO 2.5 F N B B EXCISION B FA
8 Jaya 39 6 L Y N UI 5 F N B B EXCISION B FCD
9 Eswari 34 5 L Y N UO 3 F TO H N IC M MRM M IDC
10 Jaya 43 3 R N Y UO 3 F TO H N M M MRM M IDC
11 Rangammal 40 4 R N N LO 2.5 H N M B EXCISION M IPN
12 Revathi 40 6 R Y N UO 3 H N IC M MRM M IDC
13 Kowsalya 32 8 R Y Y UI 3.5 F N B B EXCISION B FA
14 Vishalakshi 32 6 L N N UI 4 F N B B EXCISION B B PHY
15 Mallika 48 7 R N N UO 5 F N B B EXCISION B FA
16 Selvi 35 9 L N N UO 5 H N B B EXCISION B B PHY
17 Revathy 31 7 R N N LO 3 F N B IC EXCISION B FA
18 Nandhini 23 3 R Y N UO 2 F N B B EXCISION B FA
19 Jothimani 42 2 R Y N UI 4 H N M M MRM M INF DC
20 Sangeetha 30 6 L Y Y UO 5 H Y M M MRM M IDC
21 Sairabanu 40 8 L N N UI 4 H Y M M MRM M IDC
22 Ruba 35 6 L Y N LI 3 F N B B EXCISION B FA
23 Lakshmi 42 8 L N N LO 4 F N B B EXCISION B FA
24 Jothi 36 4 L N Y UO 5 H Y M M MRM M IDC
25 Nalini 24 3 R N N UI 3 F N B B EXCISION B FA
26 Poongodi 38 6 L Y N UI 3 F N B B EXCISION B FA
27 Thajnisha 45 7 L Y N LO 4 F N B IC EXCISION B FCD
28 Kaliammal 43 7 R Y N LO 5 F N IC B EXCISION B B PHY
29 Bommi 30 6 R N N UI 3 F N B B EXCISION B FA
30 Nagavalli 40 5 R N Y UO 4 H Y M M MRM M IDC
31 Kunjamalu 39 5 L Y N UI 3 F N B B EXCISION B FCD
32 Vasantha 35 4 R Y N UI 4 F N B IC EXCISION B B PHY
33 Nagamani 21 3 R Y N UO 3 F N B B EXCISION B B PHY
34 Ranjitham 26 4 R Y N UO 2 F N B B EXCISION B FA
35 Jainabegum 30 2 L N Y UO 3 H N M M BCS M IDC
36 Vijayalakshmi 28 8 R N N LI 3 F N B B EXCISION B TUB ADE
37 Shanthi 43 6 R N Y LO 4 H Y M M MRM M IDC
38 Kannammal 45 4 L N N UO 3 F N M M MRM M IDC
39 Revathi 26 5 L N N UO 2.5 F N B B EXCISION B FA
40 Tamilarasi 44 6 L N N UO 4 H Y M M MRM M DCIS
41 Suseela 43 6 R N N LO 3 F N B B EXCISION B FCD
42 Vasanthi 46 3 L N N UO 3 H N B B EXCISION B FCD
43 Latha 29 4 L Y N LO 3 F N IC B EXCISION B B PHY
44 Bharathi 38 4 R Y Y UI 4 F N B IC EXCISION B MIDP
45 Pappal 40 3 R N Y UO 3 H Y M M MRM M IDC
46 Kumutha 23 6 L Y N LO 3 F N B B EXCISION B FA
47 Shakilabanu 40 4 L N N LO 4 H N M M EXCISION M IDC
48 Saradha 39 6 L Y Y UO 3 H N M IC EXCISION M IDC
49 Sundari 36 8 R N N LI 3 F N B B EXCISION B FA
50 Manickam 44 6 R N N UO 3 H N IC M  MRM M IDC
51 Rani 35 4 R Y Y UI 2 F N B B EXCISION B FCD
52 Sandhya 50 6 L N N UI 2 F N B B EXCISION B FA
53 Gowsalya 21 4 L Y N LO 2.5 F N B B EXCISION B FA
54 Mangai 40 5 R N Y UO 4 H Y M M MRM M IDC
55 Anjali 24 4 R Y N UI 2.5 F N B B EXCISION B FA
56 Tamilselvi 38 6 L Y N LI 3 F N B B EXCISION B FCD
57 Kanimozhi 27 4 L N N UI 3.5 F N B B EXCISION B FA
58 Lalitha 33 4 L N Y UO 2 H N M M BCS M DCIS
59 Lakshmi 45 8 L Y N LO 3 F N B B EXCISION B FCD
60 Radhamani 33 9 R Y N LO 2.5 F N B B EXCISION B FA
61 Selvi 35 6 R N Y UO 3 H Y M M MRM M IDC
62 Premalatha 31 10 R Y N LI 2 F N B B EXCISION B FA
63 Mariyammal 38 4 L N N LO 4 H Y M M MRM M IDC
64 Mugambigai 22 9 R Y N LO 2.5 F N B B EXCISION B FA
65 Nagajothi 30 11 L Y N UI 2 F N B B EXCISION B FA
66 Kala 36 4 L Y N UO 3 H N IC IC EXCISION B FA
67 Sivagami 43 6 L Y N UO 4 F N B B EXCISION B B PHY
68 Rajammal 42 4 R N Y UO 4 H Y M M MRM M IDC
69 Karuppammal 56 5 R N Y UI 5 H N M IC MRM M IDC
70 Lingammal 76 2 R N N LO 3 H N IC M MRM M MUC CA 
71 Marathal 42 3 L Y N LO 2 F N B B EXCISION B FA
72 Sumathi 31 6 L Y N UO 3 F N B B EXCISION B FCD
73 Jothi 38 6 L N N UO 4 F N B B EXCISION B FCD
74 Gowri 44 4 R N N LI 3 H N M M MRM M IDC
75 Ambika 23 6 R Y N UO 2 F N B B EXCISION B FA
76 Bakyam 51 3 L N Y UO 3 H Y M M MRM M IDC
77 Veni 34 9 L Y N UO 2.5 F N B B EXCISION B FCD
78 Kala 40 10 R Y N UI 3 F N B B EXCISION B FCD
79 Dhanam 46 6 L N N UO 4 H Y M M MRM M IDC
80 Maheswari 53 4 R N Y UO 3 H Y M M MRM M IDC
81 Fathima 31 8 L Y N UO 3 F N B B EXCISION B FA
82 Latha 38 6 L Y N LO 4 F N B B EXCISION B FCD
83 Malathi 30 7 R Y N UO 5 F N B B EXCISION B BA
84 Ramuthai 48 4 L N Y LO 4 H Y M M MRM M IDC
85 Sarasammal 54 5 R Y N UO 3 H Y M M MRM M IDC
86 Selveswari 43 4 R Y N UO 4 H Y M M MRM M ILC
87 Radha 37 3 L N N LI 3 H Y B B EXCISION B FCD
88 Tamilarasi 33 5 L N N UO 4 H N M M BCS M IDC
89 Ayyammal 68 4 L Y N UO 3 H N M M MRM M MUC CA 
90 Seetha 28 9 L Y N LI 3 F N B B EXCISION B FA
91 Rajeswari 39 7 L Y N LO 2.5 F N B B EXCISION B FA
92 Latha 36 5 R N N UO 3 F N M M BCS M IDC
93 Marithai 56 3 L N N UI 2.5 H N M M MRM M IDC
94 Sarojini 42 6 R Y N LI 3 F N B B EXCISION B FCD
95 Kuruvammal 62 4 R N N UI 3 H Y M M MRM M IPC
96 Kavitha 32 1 R Y N UO 4.5 H Y IC IC EXCISION B BA
97 Lakshmi 38 6 L N N AT 3 F N B B EXCISION B FA
98 Banumathi 33 9 R Y N LO 2 F N B B EXCISION B FA
99 Nallammal 51 5 R N N UO 3 F TO H Y M M MRM M IDC
100 Dhanalakshmi 29 10 R Y N LO 2.5 F N B B EXCISION B FCD
101 Nazhrima 37 5 L N Y LO 2 H N IC M BCS M DCIS
102 Thamilselvi 39 7 R N N UO 3 H N IC B EXCISION B FCD
103 Usha 32 8 R Y Y UI 3 F N B B EXCISION B IDP
